Impact of COVID19 on clinical outcomes in hepatocellular carcinoma:A multicentre cohort study
Authors:
Preprint
- 28 September 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Introduction: The COVID-19 pandemic has caused severe disruption of healthcare services worldwide and interrupted patients’ access to essential services. During the first lockdown, many healthcare services were shut to all but emergencies. In this study, we aimed to determine the immediate and long-term indirect impact of COVID-19 health services utilisation on hepatocellular cancer (HCC) outcomes. Methods A prospective cohort study was conducted from March 1, 2020, until June 30, 2020 correlating to the first wave of the COVID-19 pandemic. Patients were enrolled from tertiary hospitals in the UK and Germany with dedicated HCC management services. All patients with current or past HCC who were discussed at a multidisciplinary meeting (MDM) were identified. Any delay to treatment (DTT) and the effect on survival at 1 year were reported. Results The median time to receipt of therapy following MDM discussion was 49 days. Patients with Barcelona Clinic Liver Cancer (BCLC) stages-A/B disease were more likely to experience DTT. Significant delays across all treatments for HCC were observed but delay was most marked for those undergoing curative therapies. Even though severe delays were observed in curative HCC treatments, this did not translate in reduced survival in patients. Conclusion Interruption of routine healthcare services because of the COVID-19 pandemic caused severe delays in HCC treatment. However, DTT did not translate to reduced survival. Longer follow is important given the delay to therapy in those receiving curative therapy.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Management of Hepatocellular Cancer in the time of SARS-CoV-2Liver International, 2020
- Evidence mounts on the disproportionate effect of COVID-19 on ethnic minoritiesThe Lancet Respiratory Medicine, 2020
- The impact of the COVID-19 pandemic on cancer careNature Cancer, 2020
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational Journal of Cancer, 2018
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysisBreast Cancer Research and Treatment, 2016
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinomaJournal of Hepatology, 2014
- Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal CancerJAMA, 2011
- Intergenerational continuities of ethnic inequalities in general health in EnglandJournal of Epidemiology and Community Health, 2008
- The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literatureRadiotherapy and Oncology, 2008